Annual Working Capital
$615.53 M
+$327.98 M+114.06%
31 December 2023
Summary:
PTC Therapeutics annual working capital is currently $615.53 million, with the most recent change of +$327.98 million (+114.06%) on 31 December 2023. During the last 3 years, it has fallen by -$338.88 million (-35.51%). PTCT annual working capital is now -35.51% below its all-time high of $954.41 million, reached on 31 December 2020.PTCT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$670.84 M
-$77.27 M-10.33%
30 September 2024
Summary:
PTC Therapeutics quarterly working capital is currently $670.84 million, with the most recent change of -$77.27 million (-10.33%) on 30 September 2024. Over the past year, it has increased by +$622.59 million (+1290.51%). PTCT quarterly working capital is now -32.26% below its all-time high of $990.35 million, reached on 30 September 2020.PTCT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +114.1% | +1290.5% |
| 3 y3 years | -35.5% | +22.9% |
| 5 y5 years | +299.5% | +7.6% |
PTCT Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -35.5% | +114.1% | -10.3% | +1290.5% |
| 5 y | 5 years | -35.5% | +299.5% | -32.3% | +1290.5% |
| alltime | all time | -35.5% | +2712.2% | -32.3% | +2946.9% |
PTC Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $670.84 M(-10.3%) |
| June 2024 | - | $748.11 M(+25.9%) |
| Mar 2024 | - | $594.19 M(-3.5%) |
| Dec 2023 | $615.53 M(+114.1%) | $615.53 M(+1175.9%) |
| Sept 2023 | - | $48.24 M(-57.4%) |
| June 2023 | - | $113.35 M(-34.0%) |
| Mar 2023 | - | $171.76 M(-40.3%) |
| Dec 2022 | $287.55 M(-35.4%) | $287.55 M(+195.9%) |
| Sept 2022 | - | $97.19 M(-23.7%) |
| June 2022 | - | $127.31 M(-57.2%) |
| Mar 2022 | - | $297.23 M(-33.2%) |
| Dec 2021 | $445.02 M(-53.4%) | $445.02 M(-18.5%) |
| Sept 2021 | - | $545.88 M(-29.6%) |
| June 2021 | - | $775.27 M(-11.0%) |
| Mar 2021 | - | $871.42 M(-8.7%) |
| Dec 2020 | $954.41 M(+75.6%) | $954.41 M(-3.6%) |
| Sept 2020 | - | $990.35 M(+145.6%) |
| June 2020 | - | $403.18 M(-15.0%) |
| Mar 2020 | - | $474.25 M(-12.7%) |
| Dec 2019 | $543.43 M(+252.7%) | $543.43 M(-12.8%) |
| Sept 2019 | - | $623.36 M(+107.1%) |
| June 2019 | - | $301.01 M(-10.4%) |
| Mar 2019 | - | $336.03 M(+118.1%) |
| Dec 2018 | $154.06 M | $154.06 M(-22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $198.36 M(-31.4%) |
| June 2018 | - | $289.17 M(+70.8%) |
| Mar 2018 | - | $169.28 M(+1.4%) |
| Dec 2017 | $167.01 M(-21.1%) | $167.01 M(+11.8%) |
| Sept 2017 | - | $149.36 M(-6.1%) |
| June 2017 | - | $158.99 M(-18.6%) |
| Mar 2017 | - | $195.31 M(-7.7%) |
| Dec 2016 | $211.66 M(-31.8%) | $211.66 M(-8.6%) |
| Sept 2016 | - | $231.68 M(-9.0%) |
| June 2016 | - | $254.53 M(-9.9%) |
| Mar 2016 | - | $282.55 M(-9.0%) |
| Dec 2015 | $310.56 M(+6.7%) | $310.56 M(-11.9%) |
| Sept 2015 | - | $352.47 M(+46.0%) |
| June 2015 | - | $241.49 M(-9.2%) |
| Mar 2015 | - | $265.86 M(-8.7%) |
| Dec 2014 | $291.10 M(+120.7%) | $291.10 M(+48.3%) |
| Sept 2014 | - | $196.25 M(-10.3%) |
| June 2014 | - | $218.73 M(-8.9%) |
| Mar 2014 | - | $240.14 M(+82.1%) |
| Dec 2013 | $131.89 M(-659.7%) | $131.89 M(-9.8%) |
| Sept 2013 | - | $146.22 M(-1.5%) |
| June 2013 | - | $148.37 M(+407.3%) |
| Mar 2013 | - | $29.25 M(-224.1%) |
| Dec 2012 | -$23.56 M(+133.5%) | -$23.56 M |
| Dec 2011 | -$10.09 M | - |
FAQ
- What is PTC Therapeutics annual working capital?
- What is the all time high annual working capital for PTC Therapeutics?
- What is PTC Therapeutics annual working capital year-on-year change?
- What is PTC Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for PTC Therapeutics?
- What is PTC Therapeutics quarterly working capital year-on-year change?
What is PTC Therapeutics annual working capital?
The current annual working capital of PTCT is $615.53 M
What is the all time high annual working capital for PTC Therapeutics?
PTC Therapeutics all-time high annual working capital is $954.41 M
What is PTC Therapeutics annual working capital year-on-year change?
Over the past year, PTCT annual working capital has changed by +$327.98 M (+114.06%)
What is PTC Therapeutics quarterly working capital?
The current quarterly working capital of PTCT is $670.84 M
What is the all time high quarterly working capital for PTC Therapeutics?
PTC Therapeutics all-time high quarterly working capital is $990.35 M
What is PTC Therapeutics quarterly working capital year-on-year change?
Over the past year, PTCT quarterly working capital has changed by +$622.59 M (+1290.51%)